Teladoc Health, Inc. balance sheet
At the end of fiscal 2025, Teladoc Health, Inc. had total assets of $2.86bn, total liabilities of $1.47bn and shareholders' equity of $1.39bn. It held $781m in cash against $995m of debt.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.4 | 0.5 | 0.7 | 0.9 | 0.9 | 1.1 | 1.3 | 0.8 | 0.8 |
| Receivables | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Inventory | — | — | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total current assets | — | 0.1 | 0.2 | 0.1 | 0.2 | 0.5 | 0.6 | 1.1 | 1.2 | 1.3 | 1.5 | 1.7 | 1.1 | 1.2 |
| Goodwill | 0.0 | 0.0 | 0.1 | 0.2 | 0.5 | 0.7 | 0.7 | 14.6 | 14.5 | 1.1 | 1.1 | 0.3 | 0.3 | 0.3 |
| Total assets | — | 0.1 | 0.2 | 0.3 | 0.8 | 1.5 | 1.6 | 17.8 | 17.7 | 4.3 | 4.4 | 3.5 | 2.9 | 2.8 |
| Accounts payable | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Deferred revenue (current) | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total current liabilities | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.9 | 0.4 | 1.4 |
| Short-term debt | — | 0.0 | 0.0 | 0.0 | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Long-term debt | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Total debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.4 | 0.4 | 1.4 | 1.2 | 1.5 | 1.5 | 1.5 | 1.0 | 1.0 |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | 2.1 | 2.0 | 1.5 | 1.5 |
| Shareholders' equity | −0.1 | −0.1 | 0.2 | 0.2 | 0.6 | 1.0 | 1.0 | 15.9 | 16.0 | 2.3 | 2.3 | 1.5 | 1.4 | 1.3 |
| Shares outstanding | — | 20m | — | 46m | 62m | 71m | 73m | — | 160m | 163m | 167m | 173m | 178m | 182m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 214 | 233 | 225 | 211 | 193 | 214 | 221 | 231 |
| Inventory | 38 | 38 | 38 | 40 | 38 | 32 | 29 | 31 |
| Total current assets | 1,664 | 1,602 | 1,073 | 1,093 | 1,119 | 1,132 | 1,148 | 1,226 |
| Goodwill | 283 | 283 | 283 | 283 | 283 | 283 | 283 | 283 |
| Total assets | 3,517 | 3,444 | 2,894 | 2,879 | 2,858 | 2,807 | 2,759 | 2,775 |
| Accounts payable | 33 | 52 | 54 | 52 | 48 | 45 | 37 | 46 |
| Deferred revenue (current) | 79 | 74 | 75 | 70 | 62 | 66 | 61 | 62 |
| Total current liabilities | 942 | 952 | 402 | 405 | 405 | 405 | 1,382 | 1,416 |
| Total liabilities | 2,025 | 2,017 | 1,472 | 1,486 | 1,473 | 1,471 | 1,449 | 1,480 |
| Shareholders' equity | 1,491 | 1,427 | 1,422 | 1,392 | 1,386 | 1,336 | 1,310 | 1,295 |
| Shares outstanding | 173m | 175m | 177m | 177m | 178m | 180m | 182m | 182m |
Compare with peers
- Veeva Systems Inc balance sheet
- Tempus AI, Inc. balance sheet
- Waystar Holding Corp. balance sheet
- Omnicell, Inc. balance sheet
- Goodrx Holdings, Inc. balance sheet
Head to head: TDOC vs VEEVTDOC vs TEMTDOC vs WAY
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies